Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 61 to 72 of 72 results for diabetic foot

  1. Managing long-term conditions in the community

    NICE's impact on managing long-term conditions in children in the community

  2. What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people with diabetes?

    higher risk of cardiovascular events and foot problems such as diabetic neuropathy (nerve damage or degeneration),...

    Research recommendation
    Published
    22 January 2021

  3. Further research is needed on the benefits and consequences of detecting preclinical diabetic peripheral neuropathy.

    research is needed on the benefits and consequences of detecting preclinical diabetic peripheral neuropathy. Any explanatory notes(if...

    Research recommendation
    Published
    3 January 2019

  4. Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus) (IPG727)

    Evidence-based recommendations on synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus). This involves replacing damaged cartilage with an artificial (synthetic) implant.

    Interventional procedures guidance
    Published
    1 June 2022
    View recommendations

    Sections for IPG727

  5. 3C Patch System for treating diabetic foot ulcers (MIB230)

    This advice has been updated and replaced by NICE medical technologies guidance 66.

    Medtech innovation briefing
    Published
    27 October 2020

  6. Research recommendations

    contact casting, hyperbaric oxygen therapy and surgical debridement for diabetic foot problems. CG119/1

  7. NICE and health inequalities

    Our health inequalities guidance supports strategies that improve population health as a whole, while offering particular benefit to the most disadvantaged

  8. Finerenone for treating chronic kidney disease in type 2 diabetes (TA877)

    Evidence-based recommendations on finerenone (Kerendia) for stage 3 and 4 chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults.

    Technology appraisal guidance
    Published
    23 March 2023
    View recommendations

    Sections for TA877

  9. The Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burns (MIB1)

    NICE has developed a Medtech Innovation Briefing (MIB) on the Versajet II hydrosurgery system

    Medtech innovation briefing
    Published
    4 February 2014

  10. Type 2 diabetes foot problems: Prevention and management of foot problems (CG10)

    This guidance has been updated and replaced by NICE guideline NG19.

    Clinical guideline
    Published
    28 January 2004

  11. Education classes essential for adults with diabetes, says NICE

    Adults with type 1 diabetes should be offered education classes to help them manage their condition, a new quality standard from NICE says.

    News
    Published
    17 August 2016

  12. Tighter blood glucose targets for people with type 1 diabetes

    New diabetes guidance includes tighter targets for blood sugar levels to help reduce variation in the management and care of condition.

    News
    Published
    26 August 2015